Customize your JAMA Network experience by selecting one or more topics from the list below.
The Original Investigation titled “Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial,”1 published online October 1, 2020, included an error in the author affiliations. The affiliations for Armando Santoro should have been Humanitas Clinical and Research Center–IRCCS, Humanitas Cancer Center, Rozzano, Milan, Italy, and Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. This article has been corrected.
Error in Author Affiliation. JAMA Oncol. 2021;7(1):140. doi:10.1001/jamaoncol.2020.6961
Artificial Intelligence Resource Center